Skip to Content

Diagnos Inc DGNOF

Morningstar Rating
$0.22 −0.01 (2.35%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

DGNOF is trading at a 95% premium.
Price
$0.22
Fair Value
$8.43
Uncertainty
Extreme
1-Star Price
$5.49
5-Star Price
$4.52
Economic Moat
Nqqm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DGNOF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.23
Day Range
$0.220.23
52-Week Range
$0.180.43
Bid/Ask
$0.22 / $0.23
Market Cap
$17.17 Mil
Volume/Avg
15,000 / 36,274

Key Statistics

Price/Earnings (Normalized)
Price/Sales
110.24
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in the business segment of Healthcare services. The company has a business presence in Canada, the United States, UAE, Saudi Arabia, Mexico, Costa Rica, and others. The company's key revenue is derived from Canada.
Sector
Healthcare
Industry
Health Information Services
Stock Style Box
Small Value
Total Number of Employees
16

Valuation

Metric
DGNOF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
110.24
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
DGNOF
Quick Ratio
0.61
Current Ratio
0.70
Interest Coverage
−5.04
Quick Ratio
DGNOF

Profitability

Metric
DGNOF
Return on Assets (Normalized)
−275.41%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−437.94%
Return on Assets
DGNOF
See how this stock stacks up to its competitors with Morningstar Investor

Health Information Services Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
GEHC
GE HealthCare Technologies Inc Common StockDwkcv$37.1 Bil
VEEV
Veeva Systems Inc Class AHpnqgzhgRsjh$34.0 Bil
SOLV
Solventum CorpLtwhsk$10.8 Bil
PMCUF
Pro Medicus LtdCyyldm$8.4 Bil
MTHRF
M3 IncQdvcllc$7.1 Bil
MTHRY
M3 Inc ADRXvyqzz$7.1 Bil
HQY
HealthEquity IncHvrhk$6.9 Bil
RCM
R1 RCM IncRpgb$5.2 Bil
DOCS
Doximity Inc Class AHpgdhh$5.2 Bil
TXG
10x Genomics Inc Ordinary Shares - Class ANkdk$3.0 Bil

Sponsor Center